Αρχειοθήκη ιστολογίου

Δευτέρα 9 Οκτωβρίου 2017

Clinical characteristics and outcomes of major salivary gland malignancies in children

Objectives/Hypothesis

Determine demographics, clinical characteristics, and survival rates for children with primary salivary gland malignancies.

Study Design

Retrospective, population-based cohort study.

Methods

All cases of primary salivary gland malignancies diagnosed between the years of 2002 and 2013 in patients ages 0 to 19 years were extracted from the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Additional variables collected included age, gender, ethnicity, tumor histological subtype, tumor size, treatment modality, vitality status, and follow-up time. Kaplan-Meier survival curves were generated.

Results

Two hundred forty-five primary salivary gland malignancies were identified (220 parotid, 25 submandibular). Median age at diagnosis was 15 years. Most patients were female (59%), white (74%), and non–Spanish/Hispanic/Latino (81%). Among parotid tumors, mean tumor size was 2.3 cm, and there were 109 (50%) mucoepidermoid carcinomas and 86 (39%) acinic cell carcinomas. Most patients underwent surgery (n = 212, 96%) and 64 (29%) received adjuvant radiation. At a mean follow-up of 62.4 months, 10 patients (5%) were deceased. Kaplan-Meier survival curves illustrated that black children exhibited higher mortality rates than white children (15.8% vs. 4.6%, log-rank = 0.0260) as did those who underwent adjuvant radiation (15.73% vs. 3.2%, log-rank = 0.0209). Among submandibular tumors, mean tumor size was 3.1 cm, and there were 11 (44%) mucoepidermoid carcinomas. All patients underwent surgery and most received adjuvant radiation (n = 15, 60%). At a mean follow-up of 51.25 months, one patient was deceased.

Conclusions

Salivary gland malignancies in children and adolescents are rare. Overall survival for both parotid and submandibular tumors in children is good.

Level of Evidence

4 Laryngoscope, 2017



http://ift.tt/2kwF8Us

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου